Business Description
Morpho Inc
ISIN : JP3927550008
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.85 | |||||
Interest Coverage | 104.14 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 10.26 | |||||
Beneish M-Score | -2.29 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.5 | |||||
3-Year EBITDA Growth Rate | -3.5 | |||||
3-Year EPS without NRI Growth Rate | 18.9 | |||||
3-Year FCF Growth Rate | -29.4 | |||||
3-Year Book Growth Rate | -13.5 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 39.45 | |||||
9-Day RSI | 47.73 | |||||
14-Day RSI | 49.93 | |||||
6-1 Month Momentum % | -5.2 | |||||
12-1 Month Momentum % | 26.72 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.18 | |||||
Quick Ratio | 6.08 | |||||
Cash Ratio | 4.99 | |||||
Days Inventory | 10.68 | |||||
Days Sales Outstanding | 51.47 | |||||
Days Payable | 26.41 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 1.6 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 61.88 | |||||
Operating Margin % | 4.59 | |||||
Net Margin % | 6 | |||||
FCF Margin % | -12.46 | |||||
ROE % | 5.65 | |||||
ROA % | 4.83 | |||||
ROIC % | 15.04 | |||||
ROC (Joel Greenblatt) % | 209.99 | |||||
ROCE % | 7.01 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 48.19 | |||||
PE Ratio without NRI | 44.92 | |||||
Shiller PE Ratio | 137.03 | |||||
PS Ratio | 2.88 | |||||
PB Ratio | 2.56 | |||||
Price-to-Tangible-Book | 2.62 | |||||
EV-to-EBIT | 26.43 | |||||
EV-to-EBITDA | 26.43 | |||||
EV-to-Revenue | 1.99 | |||||
EV-to-FCF | -15.77 | |||||
Price-to-Projected-FCF | 3.79 | |||||
Price-to-Median-PS-Value | 0.55 | |||||
Price-to-Graham-Number | 2.29 | |||||
Price-to-Net-Current-Asset-Value | 2.97 | |||||
Price-to-Net-Cash | 3.88 | |||||
Earnings Yield (Greenblatt) % | 3.79 | |||||
FCF Yield % | -4.23 | |||||
Forward Rate of Return (Yacktman) % | 9.78 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Morpho Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil 円) | 2,930.089 | ||
EPS (TTM) (円) | 34.236 | ||
Beta | 0.81 | ||
Volatility % | 32.03 | ||
14-Day RSI | 49.93 | ||
14-Day ATR (円) | 44.533776 | ||
20-Day SMA (円) | 1649.25 | ||
12-1 Month Momentum % | 26.72 | ||
52-Week Range (円) | 1220 - 2039 | ||
Shares Outstanding (Mil) | 5.23 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Morpho Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Morpho Inc Stock Events
Event | Date | Price(円) | ||
---|---|---|---|---|
No Event Data |
Morpho Inc Frequently Asked Questions
What is Morpho Inc(TSE:3653)'s stock price today?
When is next earnings date of Morpho Inc(TSE:3653)?
Does Morpho Inc(TSE:3653) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |